Categories: All postsTelco

Buy Telus over the other telcos, this portfolio manager says

Jason Del Vicario
It’s no secret that Canada’s telecommunication companies are where the smart money goes when investors are looking for a healthy dividend, but how to choose among them is the question.

Go with Telus (Telus Stock Quote, Chart TSX:T), says portfolio manager Jason Del Vicario, who points to the company’s capital investments in stretching out its fibre optic network as a difference maker.

Like much of the market, Telus had a rocky 2018, ending the year down 5.0 per cent, which was better than BCE’s 10.7 per cent drop and Shaw’s 13.9 per cent loss but less impressive compared to Rogers’ 7.7-per-cent gain.

The telcos were all winners in terms of subscriber additions in 2018, however, notably in their wireless segments where there is still room for more market penetration. Over Telus’ last reported quarter, its fiscal third for 2018 delivered on November 8, the company reported total customer growth of 187,000, with 145,000 net new wireless additions. That comes with a customer churn rate of just 0.87 per cent, said to be tops in the industry.

Telus’ piece of Canada’s wireless pie is smaller than that of BCE and Rogers but Del Vicario thinks that its buildout has been the more impressive, where Telus has invested hundreds of millions in recent years.

“We owned Telus for a brief period a while ago. They’re a pretty well-diversified company. Telus has spent a lot of money over the past few years building out their fibre optic network, whereas the likes of BCE, Rogers and Shaw haven’t necessarily done that to the same extent,” says Del Vicario to BNN Bloomberg.

“They don’t quite have the growth rate that we look for — our cutoff is 20 per cent and Telus has been in around the low to mid teens. But of all of the them, I think Telus is really a standout amongst those four,” he says.

Telus reported operating revenue of $3.77 billion in its third quarter, up from $3.40 billion a year earlier, and a profit of $447 million, up from $406 million a year earlier. That amounted to earnings of 74 cents per share, beating analysts’ expectations of 72 cents per share.

We Hate Paywalls Too!

At Cantech Letter we prize independent journalism like you do. And we don't care for paywalls and popups and all that noise That's why we need your support. If you value getting your daily information from the experts, won't you help us? No donation is too small.

Make a one-time or recurring donation

Tagged with: t
Jayson MacLean

Jayson is a writer, researcher and educator with a PhD in political philosophy from the University of Ottawa. His interests range from bioethics and innovations in the health sciences to governance, social justice and the history of ideas.

Recent Posts

Is Peloton Stock a Buy? (May, 2024)

Following news of a restructuring, Roth MKM analyst George Kelly has chopped his price target on Peloton (Peloton Stock Quote,… [Read More]

10 hours ago

Is Ascend Wellness stock a buy?

Ahead of the company's first quarter results, Beacon analyst Russell Stanley thinks Ascend Wellness (Ascend Wellness Stock Quote, Chart, News,… [Read More]

11 hours ago

Paradigm chops price target on Snipp Interactive

Following the company's fourth quarter results, Paradigm Capital analyst Daniel Rosenberg has cut his price target on Snipp Interactive (Snipp… [Read More]

11 hours ago

It’s time to buy cannabis stocks, this analyst says

A major development came down the pipe this week at the U.S. Drug Enforcement Agency has reportedly decided to reschedule… [Read More]

1 day ago

Is Generac stock a buy?

Following the company's first quarter results, Roth MKM analyst Chip Moore remains neutral on Generac Holdings (Generac Holdings Stock Quote,… [Read More]

1 day ago

Bombardier is a buy, Desjardins says (May, 2024)

The stock has climbed slowly but surely since last October. But is there still money to be made on Bombardier?… [Read More]

2 days ago